カテゴリ： MarketLine, インド, 企業調査

Dr. Reddy’s Laboratories Limited：企業の戦略・SWOT・財務分析

◆英語タイトル：Dr. Reddy's Laboratories Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY4440
◆発行会社（調査会社）：MarketLine
◆発行日：2020年2月
◆ページ数：52
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インド
◆産業分野：Pharmaceuticals and Healthcare
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Dr. Reddy’s Laboratories Limited – Strategy, SWOT and Corporate Finance Report
Summary

Dr. Reddy’s Laboratories Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Dr. Reddy’s Laboratories (DRL or ‘the company’) is an integrated pharmaceutical company that offers generics, over the counter, active pharmaceutical ingredients and proprietary products. The generics products are ready for consumption by the customer product and specified for the areas of gastrointestinal, cardiovascular, pain management, oncology, anti-infectives, pediatrics and central nervous system. It also offers pharmaceutical services and active ingredients product that consists of active pharmaceutical products or bulk drugs. DRL is engaged in the discovery of new chemical entities for the areas of metabolic disorders, pain and inflammation. The company operates in India, North America, Europe, Russia and other countries of the former Soviet Union. DRL is headquartered in Hyderabad,Telengana, India.

Scope

- Detailed information on Dr. Reddy’s Laboratories Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Dr. Reddy’s Laboratories Limited in the form of a SWOT analysis
- An in-depth view of the business model of Dr. Reddy’s Laboratories Limited including a breakdown and examination of key business segments
- Intelligence on Dr. Reddy’s Laboratories Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Dr. Reddy’s Laboratories Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Dr. Reddy’s Laboratories Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Dr. Reddy’s Laboratories Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Dr. Reddy’s Laboratories Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Dr. Reddy’s Laboratories Limited: Company Overview
Dr. Reddy’s Laboratories Limited: Overview and Key Facts
Dr. Reddy’s Laboratories Limited: Overview
Dr. Reddy’s Laboratories Limited: Key Facts
Dr. Reddy’s Laboratories Limited: Key Employees
Dr. Reddy’s Laboratories Limited: Key Employee Biographies
Dr. Reddy’s Laboratories Limited: Major Products and Services
Dr. Reddy’s Laboratories Limited: Company History
Dr. Reddy’s Laboratories Limited: Management Statement
Dr. Reddy’s Laboratories Limited: Locations and Subsidiaries
Dr. Reddy’s Laboratories Limited: Key Competitors
Dr. Reddy’s Laboratories Limited: Company Analysis
Dr. Reddy’s Laboratories Limited: Business Description
Dr. Reddy’s Laboratories Limited: SWOT Analysis
Dr. Reddy’s Laboratories Limited: SWOT Overview
Dr. Reddy’s Laboratories Limited: Strengths
Dr. Reddy’s Laboratories Limited: Weaknesses
Dr. Reddy’s Laboratories Limited: Opportunities
Dr. Reddy’s Laboratories Limited: Threats
Dr. Reddy’s Laboratories Limited: Corporate Financial Deals Activity
Dr. Reddy’s Laboratories Limited: Financial Deals Overview
Dr. Reddy’s Laboratories Limited: Targets and Partners
Dr. Reddy’s Laboratories Limited: Top Deals 2016 – 2020YTD*
Dr. Reddy’s Laboratories Limited: Advisors
Dr. Reddy’s Laboratories Limited: Top Financial Advisors
Dr. Reddy’s Laboratories Limited: Mergers and Acquisitions
Dr. Reddy’s Laboratories Limited: Partnership
Dr. Reddy’s Laboratories Limited: Divestments
Dr. Reddy’s Laboratories Limited: Recent Developments
Dr. Reddy’s Laboratories Limited: News and Events Summary
Dr. Reddy’s Laboratories Limited: Business Expansion
Dr. Reddy’s Laboratories Limited: Corporate Governance
Dr. Reddy’s Laboratories Limited: Financial Deals
Dr. Reddy’s Laboratories Limited: Financial Performance
Dr. Reddy’s Laboratories Limited: Regulatory and Legal Events
Dr. Reddy’s Laboratories Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Dr. Reddy's Laboratories Limited: Key Facts
Table 2: Dr. Reddy's Laboratories Limited: Key Employees
Table 3: Dr. Reddy's Laboratories Limited: Company History
Table 4: Dr. Reddy's Laboratories Limited: Locations and Subsidiaries
Table 5: Dr. Reddy's Laboratories Limited: Key Competitors
Table 6: Dr. Reddy's Laboratories Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Dr. Reddy's Laboratories Limited: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Dr. Reddy's Laboratories Limited: M&A Average Deal Size - Value (US$m)
Table 9: Dr. Reddy's Laboratories Limited: Targets and Partners
Table 10: Dr. Reddy's Laboratories Limited: Top Deals 2016 - 2020YTD*
Table 11: Dr. Reddy's Laboratories Limited: Financial Advisor Ranking by Value (US$m)
Table 12: Dr. Reddy's Laboratories Limited: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Dr. Reddy's Laboratories Limited: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Dr. Reddy's Laboratories Limited: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 15: Dr. Reddy's Laboratories Limited: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 16: Dr. Reddy's Laboratories Limited: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 17: Dr. Reddy's Laboratories Limited: Divestments by Geography (2016 - YTD*2020)
Table 18: Dr. Reddy's Laboratories Limited: News and Events Summary
Table 19: Dr. Reddy's Laboratories Limited: Business Expansion
Table 20: Dr. Reddy's Laboratories Limited: Corporate Governance
Table 21: Dr. Reddy's Laboratories Limited: Financial Deals
Table 22: Dr. Reddy's Laboratories Limited: Financial Performance
Table 23: Dr. Reddy's Laboratories Limited: Regulatory and Legal Events
Table 24: Dr. Reddy's Laboratories Limited: Strategy and Operations

★海外企業調査レポート[Dr. Reddy’s Laboratories Limited：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • 84 Lumber Company：企業の戦略・SWOT・財務情報
    84 Lumber Company - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Beijer Ref Ab：企業のM&A・事業提携・投資動向
    Beijer Ref Ab - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beijer Ref Ab Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • OncoSil Medical Ltd (OSL)-医療機器分野：企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …
  • Rosseti (RSTI)：企業の財務・戦略的SWOT分析
    Rosseti (RSTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Centogene AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • SymBio Pharmaceuticals Ltd (4582)：企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • Kallpa Generacion SA：企業の発電所・SWOT分析2018
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Mediobanca Private Banking：企業の戦略・SWOT・財務情報
    Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report Summary Mediobanca Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Nexus AG (NXU)：企業の財務・戦略的SWOT分析
    Summary Nexus AG (Nexus) is a healthcare technology company that provides healthcare software solutions. The company provides products such as NEXUS and HIS, a hospital information system; NEXUS and DIS, a special ward and department solutions; and NEXUS and QM, a solution in quality management, amo …
  • Genzyme Corp-医療機器分野：企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS)：石油・ガス：M&Aディール及び事業提携情報
    Summary PT Perusahaan Gas Negara (Persero) Tbk (PGN) is a downstream energy that transmits and distributes natural gas. The company plans, constructs and develops downstream natural gas businesses and carries out processing, transportation, storage and trading of natural gas. It produces, trades and …
  • Vienna Insurance Group AG：企業のM&A・事業提携・投資動向
    Vienna Insurance Group AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vienna Insurance Group AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Kimball Electronics Inc (KE)：企業の財務・戦略的SWOT分析
    Kimball Electronics Inc (KE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Biolase Inc (BIOL)：企業の財務・戦略的SWOT分析
    Biolase Inc (BIOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • FPT Securities Joint Stock Company (FTS)：企業の財務・戦略的SWOT分析
    FPT Securities Joint Stock Company (FTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Parkland Fuel Corporation (PKI)：石油・ガス：M&Aディール及び事業提携情報
    Summary Parkland Fuel Corp (Parkland) is a downstream energy company. It markets various fuel and petroleum products, including gasoline, propane, lubricants, diesel, heating oil, and other petroleum products. The company maintains a portfolio of supply relationships, storage infrastructure, and thi …
  • Tillotts Pharma AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Tillotts Pharma AG (Tillotts) a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of vari …
  • Northeastern Rural Electric Membership Corp：企業の戦略的SWOT分析
    Northeastern Rural Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • SurgaColl Technologies Ltd：製品パイプライン分析
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops regenerative technologies. The company’s products comprise hydroxycoll and chondrocoll. It offers regenerative solutions in the field of bone, cartilage and osteochondral tissue regeneration. SurgaC …
  • B&N Bank (Joint-Stock Company)：企業の戦略・SWOT・財務情報
    B&N Bank (Joint-Stock Company) - Strategy, SWOT and Corporate Finance Report Summary B&N Bank (Joint-Stock Company) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆